News | August 13, 2025
Apollo Hospitals Q1 FY26 PAT up 42% to Rs. 433 Cr
Apollo has also announced plans to add over 4,300 beds in the next five years with an investment of over Rs. 7,600 crore
Apollo has also announced plans to add over 4,300 beds in the next five years with an investment of over Rs. 7,600 crore
The company reported revenue from operations at Rs. 6,573.7 crore, up 6 per cent YoY
AINU is set to accelerate its expansion footprint, enhance operational capabilities
Treatment with the selective NaV1.8 pain signal inhibitor VX-993 after bunionectomy surgery did not meet the primary endpoint
The expanded partnership includes cGMP manufacturing, technology transfer for both drug substance and product
For patients with resectable early-stage gastric and gastroesophageal junction cancers
European Commission granted approval of darolutamide in combination with androgen deprivation therapy (ADT) for patients with metastatic hormone-sensitive prostate cancer (mHSPC)
Loteprednol Etabonate Ophthalmic Suspension, 0.5% is indicated for the treatment of steroidresponsive inflammatory conditions of the palpebral and bulbar conjunctiva
The company’s largest center for medical device applications, serving the entire Asian market
Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
Subscribe To Our Newsletter & Stay Updated
